Repertoire Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, has entered a multi-year strategic collaboration with Bristol Myers Squibb to...

View the Online Magazine

Launches

Beckman Coulter’s DxI 9000 Immunoassay Analyzer extends menu with new CE-marked hepatitis assays at ESCMID Global

Beckman Coulter Diagnostics, a leader in clinical diagnostics, announced today, ahead of the congress of the European Society of Clinical Microbiology and Infectious Diseases...

Getinge and CellRev launch pioneering adherent cell expansion platform

CellRev, in partnership with Getinge, has launched a breakthrough adherent cell expansion platform, Livit ACE. Designed to eliminate many of the limitations and inefficiencies associated...

Data on over 2,300 lung cancer biomarkers mapped in new global database

A new database has been created to support pharmaceutical and biotech companies in the creation of new drugs to treat lung cancer, bringing the...

Suppliers Guide

Check out our Suppliers Guide or contact our team and get your company listed

Subscribe

Keep up with what's happening in the industry and subscribe to our weekly newsletter

Events

Get your event seen by potential candidates on the world's leading industry site.

Supply Chain

ACG awarded ‘Great Place To Work’ certification for a fourth consecutive year

ACG, the world’s largest integrated supplier and service provider to the pharmaceutical industry, is delighted to announce that for the fourth consecutive year, it...

Emergent BioSolutions receives $75m contract option from BARDA to procure doses of anthrax vaccine

The Biomedical Advanced Research and Development Authority (BARDA) within the Administration for Strategic Preparedness and Response at the United States Department of Health and...

UK Health Security Agency agrees vaccine deal

The UK Health Security Agency (UKHSA) has agreed a deal for millions of life-saving vaccines to be produced in the UK if a future...

Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK

A. Menarini Farmaceutica Internazionale SRL (Menarini) has become the exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (a fixed-dose combination of canagliflozin and metformin) in the United...

Approvals

Manufacturiung

Finance

Research & Development
Latest

Repertoire and Bristol Myers Squibb to develop tolerizing vaccines for autoimmune diseases

Repertoire Immune Medicines, a biotechnology company pioneering the discovery and development of programmable T cell targeted immune medicines, has entered a multi-year strategic collaboration...

Regeneron and Mammoth collaborate on CRISPR-based gene editing for multiple diseases

Regeneron Pharmaceuticals and Mammoth Biosciences have formed a collaboration to research, develop and commercialize in vivo CRISPR-based gene editing therapies for multiple tissues and...

AskBio receives FDA Fast Track Designation for investigational gene therapy program in congestive heart failure

Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, has been...

Genomics plc and GSK establish precision medicine collaboration

Genomics plc and GSK have established a new collaboration to explore the potential for using polygenic risk scores (PRS) in clinical trials, to improve...

After record low global pharma companies’ return on R&D investment increases

The world’s top 20 pharmaceutical companies collectively spent $145 billion on their research and development (R&D) investments in 2022-23, up from $139 billion in...

Appointments